Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Gains from Investment Securities (2021 - 2025)

Senti Biosciences has reported Gains from Investment Securities over the past 5 years, most recently at $1.6 million for Q2 2025.

  • For Q2 2025, Gains from Investment Securities rose 0.82% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $3.5 million, up 11.36%, while the annual FY2024 figure was -$20000.0, 90.34% up from the prior year.
  • Gains from Investment Securities for Q2 2025 was $1.6 million at Senti Biosciences, down from $1.9 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.9 million in Q1 2025 and troughed at -$9.5 million in Q4 2022.
  • A 5-year average of -$1.1 million and a median of $61000.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: crashed 105222.22% in 2022 and later surged 4074.29% in 2024.
  • Year by year, Gains from Investment Securities stood at $9000.0 in 2021, then crashed by 105222.22% to -$9.5 million in 2022, then soared by 88.31% to -$1.1 million in 2023, then surged by 107.87% to $87000.0 in 2024, then surged by 1739.08% to $1.6 million in 2025.
  • Business Quant data shows Gains from Investment Securities for SNTI at $1.6 million in Q2 2025, $1.9 million in Q1 2025, and $87000.0 in Q4 2024.